Fortress Biotech (FBIO) Reports Updated Phase 1b Data Presented at 16th International Symposium on Amyloidosis
Tweet Send to a Friend
Caelum Biosciences, Inc., a Fortress Biotech, Inc. (NASDAQ: FBIO) Company developing treatments for rare and life-threatening diseases, today announced a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE